‘Alarmingly high’ risk of death for people with opioid use disorder in general medical care

Public Release: 24-Apr-2017 Wolters Kluwer Health April 24, 2017 – Almost one-fifth of patients with opioid use disorder (OUD) in a large healthcare system died during a four-year follow-up period, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by…

‘Harmless’ painkillers associated with up to 50% increased risk of cardiac arrest

Public Release: 15-Mar-2017 Researchers advise avoiding diclofenac and limiting ibuprofen to 1200 mg per day European Society of Cardiology Sophia Antipolis, 15 March 2017: Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal – Cardiovascular Pharmacotherapy.1…

Popular heartburn drugs linked to gradual yet ‘silent’ kidney damage

Public Release: 22-Feb-2017   Most patients don’t experience acute kidney problems beforehand Washington University in St. Louis   Caption Taking popular heartburn medication for prolonged periods may lead to serious kidney damage, even in people who show no signs of kidney problems, according to researchers at Washington University School of Medicine in St. Louis and…

Antibiotics, not dirty hospitals, the main cause of C. difficile epidemic

Public Release: 24-Jan-2017   University of Oxford   The study concluded that overuse of antibiotics like ciprofloxacin led to the outbreak of severe diarrhoea caused by C. difficile that hit headlines from 2006 onwards. The outbreak was stopped by substantially reducing use of ciprofloxacin and related antibiotics. Inappropriate use and widespread over prescribing of fluoroquinolone…

Medications for heartburn and gastric issues could lower possibility of survival and recovery for cancer patients

Public Release: 15-Dec-2016 Avoiding over-the-counter heartburn meds could save cancer patients’ lives   University of Alberta Faculty of Medicine & Dentistry   IMAGE: Proton pump inhibitors (PPIs), which are very common medications for heartburn and gastrointestinal bleeding, decrease effects of capecitabine, a type of chemotherapy usually prescribed to gastric cancer patients. Credit: Melissa Fabrizio Something…

Aspartame may prevent, not promote, weight loss by blocking intestinal enzyme’s activity

Public Release: 22-Nov-2016   Mass. General study identifies possible mechanism behind sugar substitute’s lack of effectiveness Massachusetts General Hospital A team of Massachusetts General Hospital (MGH) investigators has found a possible mechanism explaining why use of the sugar substitute aspartame might not promote weight loss. In their report published online in Applied Physiology, Nutrition and…

Yearly exposure to chemicals dangerous to hormone function burdens Americans with hundreds of billions in health care costs and lost earnings

Public Release: 17-Oct-2016   NYU Langone Medical Center / New York University School of Medicine   Caption Annual health care costs and lost earnings in the United States from low-level but daily exposure to hazardous chemicals commonly found in plastic bottles, metal food cans, detergents, flame retardants, toys, cosmetics, and pesticides, exceeds $340 billion, according…

Men born to in vitro fertilization likely to be infertile themselves

Public Release: 5-Oct-2016 First results on semen quality from the world’s oldest group of ICSI men European Society of Human Reproduction and Embryology First results from the world’s oldest group of young men conceived by means of intracytoplasmic sperm injection (ICSI) fertility treatment because of their fathers’ infertility have shown that they have lower sperm…

New Research indicates its the amount of gluten that triggers celiac disease not the timing

Public Release: 3-Oct-2016 New research delimits the possible causes of celiac disease Lund University The amount of gluten could be a more important clue than breast-feeding or the timing of the introduction of gluten for continued research into the causes of celiac disease (gluten intolerance). This is one of the findings from several extensive studies…